title: Use of pamidronate in the management of acute cancer-related hypercalcemia in children.
authors.forename: T
authors.initials: T
authors.lastname: Kutluk
authors.forename: C
authors.initials: C
authors.lastname: Akyüz
authors.forename: B
authors.initials: B
authors.lastname: Yalçin
authors.forename: A
authors.initials: A
authors.lastname: Varan
authors.forename: M
authors.initials: M
authors.lastname: Büyükpamuküçu
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D004164:Diphosphonates / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology* / Q000628:therapy*; D006996:Hypocalcemia / Q000139:chemically induced; D017674:Hypophosphatemia / Q000139:chemically induced; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008274:Magnesium / Q000097:blood; D000077268:Pamidronate
chemical_list: D000970:Antineoplastic Agents; D004164:Diphosphonates; D008274:Magnesium; D000077268:Pamidronate